• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510400
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
 
Event Description
It was reported that on (b)(6) 2009 the patient was pre-operatively diagnosed with spondylolisthesis, l4-5, grade two.Foraminal stenosis, l4-5, severe bilaterally.Lumbar radiculopathy and underwent the following procedures: bilateral complete laminectomy, l4-5 including completing facetectomy, l4-5 bilaterally for decompression of the thecal sac and roots.Complete discectomy at l4-5.Posterior lumbar interbody arthrodesis at l4-5 using a modular peek spacer, interbody device packed with bone morphogenic protein.Open reduction of spondylolisthesis.Posterior instrumented fusion l4-5, using the screw system.Posterolateral arthrodesis l4-5 using morselized autograft as well as with constituted bone morphogenic protein.Harvesting of morselized autograft via the same incision.As per the op-notes: ¿a 10mm x 20mm x 0 degree modular peek spacer was selected.This was the packed full of allograft that had been reconstituted with bone morphogenic protein¿.A high speed drill was used to decorticate the transverse processes of l4 and l5 bilaterally and a posterolateral arthrodesis was accomplished using morselized autograft, as well as the remaining vitoss ba reconstituted bone morphogenic protein.¿ post operatively the patient reported back pain and underwent a revision surgery in (b)(6) 2014.
 
Manufacturer Narrative
Additional information.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
stacie ziemba
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6649458
MDR Text Key77823138
Report Number1030489-2017-01593
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number7510400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/22/2017
Initial Date FDA Received06/19/2017
Supplement Dates Manufacturer ReceivedNot provided
05/22/2017
Supplement Dates FDA Received06/21/2017
10/04/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
-
-